Alla studier
Aktiv men inte rekryterandeOBSERVATIONELL

Is Fat in the Liver a Marker of Post-Pregnancy Glycaemic Deterioration in Women With Gestational Diabetes?

This study aims to understand if having fat in the liver (a condition called NAFLD) affects how well a woman's body handles sugar after she's had gestational diabetes during pregnancy. We use routine ultrasound scans and special MRI scans to look for NAFLD. We're interested in how NAFLD might relate to changes in blood sugar levels and how the body uses insulin in the period after giving birth. This research isn't trying to predict if someone will get Type 2 diabetes, but rather to see if NAFLD signals an early worsening of blood sugar control. This information is important because knowing about these early changes can help healthcare professionals provide better advice and support for a healthy lifestyle, which can help prevent further health problems.

Överblick

Status
Aktiv men inte rekryterande
Sponsor
University Hospitals of North Midlands NHS Trust
Inskrivningsmål
189
Starta
05 May 2019
Beräknad slutförande
30 dec 2026

Vad handlar denna studie om?

This study is focusing on women who have had gestational diabetes – a type of diabetes that develops during pregnancy and usually goes away after the baby is born. We're particularly interested in whether finding extra fat in the liver, a condition known as Non-Alcoholic Fatty Liver Disease (NAFLD), can tell us something important about a woman's health after pregnancy.

Our main goal is to see if NAFLD, which can be spotted during routine ultrasound scans, means there will be changes in how well the body manages sugar levels in the months after giving birth. We're also looking at how NAFLD might be connected to how effectively the body uses insulin, which is crucial for controlling blood sugar.

While we're not trying to find out if NAFLD directly leads to Type 2 diabetes down the line (that would need a much longer study), we *are* trying to understand if it's an early sign that blood sugar control is getting worse. This is really important because if we can identify women who are at higher risk of these changes early on, their doctors can give them tailored advice and support to encourage healthy lifestyle choices. These choices are known to be very effective in preventing further health issues, including the development of Type 2 diabetes.

Viktiga punkter

  • Researches the link between liver fat (NAFLD) and blood sugar changes after gestational diabetes.
  • Uses routine ultrasound and MRI scans to gather information.
  • Aims to identify early signs of worsening blood sugar control, not to diagnose future Type 2 diabetes.
  • Findings could help healthcare providers offer better support and advice for a healthy lifestyle.
  • Participation involves an MRI scan and blood tests after pregnancy.
  • Du kan dra dig ur studien när som helst.

Vem kan vara berättigad?

This study is looking for women who are aged 18 or older.

You must be pregnant and have been diagnosed with gestational diabetes using a specific blood sugar test called an Oral Glucose Tolerance Test (OGTT).

However, you won't be able to join if you had Type 1 or Type 2 diabetes before you got pregnant, or if you have any existing liver conditions, including liver disease caused by alcohol. Also, if you can't or don't want to give your consent to be part of the study, or if you have any health reasons that mean you can't have an MRI scan, you wouldn't be able to participate.

Kan denna studie passa dig?

Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.

  1. Är du 18 år eller äldre?
  2. Are you currently pregnant and have been diagnosed with gestational diabetes?
  3. Do you have any pre-existing Type 1 or Type 2 diabetes?
  4. Do you have any existing liver conditions?
  5. Kan du genomgå en MR-skanning?
Svara på varje fråga för att se ditt resultat.

Vad innebär deltagande?

If you decide to take part in this study, you would have an MRI scan after your pregnancy. This scan is a special type of imaging that helps us look for fat in the liver. You would also have some blood tests to check your blood sugar levels and how your body uses insulin. The study doesn't involve taking any new medications. We would also use information from your routine ultrasound scans that you have during pregnancy. The total duration of your active participation, including the scan and tests, would be arranged after your baby is born.

Potentiella risker och fördelar

Taking part in this study won't directly improve your health, but the information we gather could help future women with gestational diabetes by improving our understanding of their health needs. There are no known serious risks associated with an MRI scan, though some people find them noisy or restrictive. You have the right to withdraw from the study at any time without giving a reason, and this will not affect your medical care. All your personal data will be kept confidential.

Platser (1)

  • University Hospitals of North Midlands NHS Trust
    Verifierat postnummer
    Stoke-on-Trent, United Kingdom

Vanliga frågor

What is Gestational Diabetes?

Gestational diabetes is a type of diabetes that develops during pregnancy and usually goes away after the baby is born. It means your blood sugar levels are too high during pregnancy.

What is NAFLD?

NAFLD stands for Non-Alcoholic Fatty Liver Disease. It's when there's too much fat in the liver, not caused by drinking alcohol.

Kommer jag att behöva ta ny medicin?

Nej, denna studie innebär inte att ta några nya mediciner.

Does this study predict if I will get Type 2 diabetes?

No, this study is not designed to predict if you will get Type 2 diabetes in the future. It's looking for early changes in blood sugar control after pregnancy.

Vad är en MR-skanning?

An MRI scan uses strong magnets and radio waves to create detailed images of the inside of your body, without using X-rays.

Hur du får reda på mer

Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.

Diskussion

Gemenskapsdiskussion

Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.